Vladimir Torchilin
Molecular Biology · 2001–2019
A researcher in the Science corpus: 15 papers; trusts 17 researchers and is trusted by 82 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 98 citations into it; #313 of 17,836 by trust here, #1,591 by citations
- Biomaterials — 88 citations into it; #47 of 2,152 by trust here, #326 by citations
- Biomedical Engineering — 57 citations into it; #868 of 10,753 by trust here, #3,273 by citations
- Oncology — 30 citations into it
- Cancer Research — 24 citations into it
- Materials Chemistry — 24 citations into it
- Pharmaceutical Science — 17 citations into it
- Physiology — 5 citations into it
Whom Vladimir Torchilin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- H. Maeda
- Christopher A. Lipinski
- Iroon Polytechniou
- You Han Bae
- Y. Barenholz
- A. Kabanov
- F. Danhier
- Mauro Ferrari
- Rakesh K. Jain
- K. Greish
Who trusts Vladimir Torchilin overall
- Pranali P. Deshpande
- Phatsapong Yingchoncharoen
- Conroy Sun
- S. Biswas
- J. S. Suk
- D. Kalinowski
- S. Ganta
- Yan Fang
- A. Anselmo
- N. Bertrand
Papers from Vladimir Torchilin's perspective
Ordered by how strongly the researchers Vladimir Torchilin trusts endorse each paper. Same corpus, a different order for every researcher.
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Nanoparticles for drug delivery in cancer treatment. (Urologic oncology)
- Active targeting schemes for nanoparticle systems in cancer therapeutics. (Advanced Drug Delivery Reviews)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Structure and design of polymeric surfactant-based drug delivery systems. (Journal of Controlled Release)
- Multifunctional nanocarriers. (Advanced Drug Delivery Reviews)
- Paul Ehrlich's magic bullet concept: 100 years of progress (Nature Reviews. Cancer)
- HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES
- Targeted pharmaceutical nanocarriers for cancer therapy and imaging (AAPS Journal)
- Mesoporous Silica Nanoparticle Nanocarriers – Biofunctionality and Biocompatibility (Accounts of Chemical Research)
Their papers
- Recent advances with liposomes as pharmaceutical carriers (2005) — 4,931 citations
- Tumor delivery of macromolecular drugs based on the EPR effect. (2011) — 1,895 citations
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors (2001) — 791 citations
- Targeted pharmaceutical nanocarriers for cancer therapy and imaging (2007) — 744 citations
- Multifunctional nanocarriers. (2006) — 852 citations
- Structure and design of polymeric surfactant-based drug delivery systems. (2001) — 1,632 citations
- Micellar Nanocarriers: Pharmaceutical Perspectives (2006) — 1,794 citations
- Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. (2005) — 657 citations
- Current trends in the use of liposomes for tumor targeting (2013) — 613 citations
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery (2014) — 1,433 citations
- Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. (2004) — 629 citations
- Hydrogels and Their Applications in Targeted Drug Delivery (2019) — 575 citations
- Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives. (2018) — 370 citations
- New Developments in Liposomal Drug Delivery. (2015) — 1,373 citations
- Cell-penetrating peptides: breaking through to the other side. (2012) — 666 citations